| scholarly article | Q13442814 |
| P50 | author | Carla E Ramacciotti | Q117231903 |
| Elisabetta Coli | Q117231924 | ||
| Donatella Marazziti | Q27149392 | ||
| Cristina Segura-García | Q42663342 | ||
| Francesca Brambilla | Q48309071 | ||
| Armando Piccinni | Q57420740 | ||
| P2093 | author name string | Liliana Dell'osso | |
| P2860 | cites work | A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge-eaters | Q68519546 |
| Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eaters | Q72267762 | ||
| The nature of body image disturbance in patients with binge eating disorder | Q73169377 | ||
| Group interpersonal psychotherapy may be as effective as group cognitive behavioural therapy for overweight people with binge eating disorder | Q73327435 | ||
| Weight maintenance and relapse in obesity: a qualitative study | Q73670658 | ||
| The prognostic significance of regular binge eating in extremely obese gastric bypass patients: 12-month postoperative outcomes | Q79459268 | ||
| Suicides following bariatric surgery for the treatment of obesity | Q80151372 | ||
| Body image interventions in cognitive-behavioural therapy of binge-eating disorder: a component analysis | Q80593203 | ||
| Brief, four-session group CBT reduces binge eating behaviors among bariatric surgery candidates | Q83404263 | ||
| Diagnosis and management of binge eating disorder | Q24670069 | ||
| World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders | Q28249390 | ||
| Sodium oxybate in the treatment of binge eating disorder: an open-label, prospective study | Q28275217 | ||
| Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health | Q28288766 | ||
| Zonisamide Combined with Cognitive Behavioral Therapy in Binge Eating Disorder: A One-year Follow-up Study | Q33570632 | ||
| Self-reported binge eating in severe pediatric obesity: impact on weight change in a randomized controlled trial of family-based treatment | Q33937671 | ||
| The cognitive-behavioral model of bulimia nervosa: a direct evaluation | Q34113348 | ||
| Heterogeneity moderates treatment response among patients with binge eating disorder | Q34167734 | ||
| Bupropion versus sertraline in the treatment of depressive patients with binge eating disorder: retrospective cohort study | Q34217281 | ||
| A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder. | Q34525822 | ||
| Axis I psychopathology in bariatric surgery candidates with and without binge eating disorder: results of structured clinical interviews | Q34892028 | ||
| Binge eating disorder and the outcome of bariatric surgery at one year: a prospective, observational study | Q34892741 | ||
| Does rapid response to two group psychotherapies for binge eating disorder predict abstinence? | Q34959303 | ||
| Risk of Suicide after Long-term Follow-up from Bariatric Surgery | Q34976773 | ||
| Psychological aspects of weight maintenance and relapse in obesity | Q35006110 | ||
| Reconceptualizing causative factors and intervention strategies in the eating disorders: A shift from body image to self-concept impairments | Q35109819 | ||
| Moderators of dialectical behavior therapy for binge eating disorder: results from a randomized controlled trial | Q35161167 | ||
| Cognitive-behavioral therapy, behavioral weight loss, and sequential treatment for obese patients with binge-eating disorder: a randomized controlled trial | Q35673560 | ||
| Rapid response predicts 12-month post-treatment outcomes in binge-eating disorder: theoretical and clinical implications | Q35784723 | ||
| Association between obesity and psychiatric disorders in the US adult population | Q35880425 | ||
| Binge eating disorder: current knowledge and future directions | Q36340268 | ||
| Binge eating disorder treatment: a systematic review of randomized controlled trials | Q36763728 | ||
| Review and meta-analysis of pharmacotherapy for binge-eating disorder | Q36832927 | ||
| Classification of eating disorders: toward DSM-V. | Q36904752 | ||
| The use of sibutramine in the management of obesity and related disorders: an update | Q37202159 | ||
| Treatment of obese patients with binge eating disorder using topiramate: a review | Q37271279 | ||
| The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions | Q37494318 | ||
| Preoperative predictors of weight loss following bariatric surgery: systematic review | Q37915396 | ||
| Novel treatment options of binge eating disorder | Q37952369 | ||
| Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial | Q38400837 | ||
| Binge eating disorder pharmacotherapy clinical trails--who is left out? | Q40062592 | ||
| Comorbidity and binge eating disorder | Q40966505 | ||
| Binge eating disorder: clinical features and treatment of a new diagnosis | Q41652625 | ||
| Duloxetine in obese binge eater outpatients: preliminary results from a 12-week open trial | Q42624952 | ||
| Placebo controlled double-blind trial of fluvoxamine maleate in the obese | Q43510331 | ||
| Long-term outcomes following laparoscopic adjustable gastric banding: postoperative psychological sequelae predict outcome at 5-year follow-up | Q43758326 | ||
| Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients | Q44167477 | ||
| A Randomized, Double-blind, Placebo-Controlled Study of Sibutramine in the Treatment of Binge-Eating Disorder | Q44650361 | ||
| Meta-analysis of the effectiveness of psychological and pharmacological treatments for binge eating disorder. | Q46032645 | ||
| Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial | Q46055809 | ||
| Restraint, hunger, and disinhibition following treatment for binge-eating disorder | Q46171260 | ||
| Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder | Q46564748 | ||
| Daily high doses of fluoxetine for weight loss and improvement in lifestyle before bariatric surgery. | Q46730308 | ||
| Dialectical behavior therapy for binge eating disorder | Q46795635 | ||
| Variables associated with disturbed eating habits and overvalued ideas about the personal implications of body shape and weight in a female adolescent population | Q47179350 | ||
| Invited Commentary: Body Mass Index and Suicide--Untangling an Unlikely Association | Q47259987 | ||
| Weight change, weight cycling and mortality in the ERFORT Male Cohort Study | Q47276301 | ||
| Eating behavior as a prognostic factor for weight loss after gastric bypass | Q47280970 | ||
| Recorded food intake of obese women with binge eating disorder before and after weight loss | Q47378527 | ||
| Weight loss and postoperative complications in morbidly obese patients with binge eating disorder treated by laparoscopic adjustable gastric banding. | Q47386588 | ||
| Positive response to binge eating intervention enhances postoperative weight loss | Q47392692 | ||
| Psychological predictors of weight regain in obesity. | Q47406591 | ||
| Characteristics of eating disorder patients without a drive for thinness | Q47430231 | ||
| Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial | Q47582258 | ||
| Acamprosate in the treatment of binge eating disorder: a placebo-controlled trial | Q47600161 | ||
| Binge eating disorder: prevalence and psychopathological features in a clinical sample of obese people in Italy | Q47674403 | ||
| Night eating syndrome and binge eating disorder among persons seeking bariatric surgery: prevalence and related features | Q48492412 | ||
| Associations of negative affect and eating behaviour in obese women with and without binge eating disorder | Q48891602 | ||
| Relationship between bipolar illness and binge-eating disorders. | Q50967629 | ||
| The prevalence of binge eating disorder and borderline personality symptomatology among gastric surgery patients. | Q51711615 | ||
| Grazing and loss of control related to eating: two high-risk factors following bariatric surgery. | Q51717067 | ||
| Prevalence of all relevant eating disorders in patients waiting for bariatric surgery: a comparison between patients with and without eating disorders. | Q51809254 | ||
| Shared psychopathology in obese subjects with and without binge-eating disorder. | Q51889985 | ||
| Specificity of self-concept disturbances in eating disorders. | Q51942902 | ||
| Comparison of patients with bulimia nervosa, obese patients with binge eating disorder, and nonobese patients with binge eating disorder. | Q51946660 | ||
| Imipramine and diet counseling with psychological support in the treatment of obese binge eaters: a randomized, placebo-controlled double-blind study. | Q53927156 | ||
| Eating disorders | Q56093429 | ||
| Five-year longitudinal predictive factors for disordered eating in a population-based sample of overweight adolescents: Implications for prevention and treatment | Q57678607 | ||
| Binge eating disorder in extreme obesity | Q58402025 | ||
| P433 | issue | 1 | |
| P921 | main subject | eating disorder | Q373822 |
| binge eating | Q2303219 | ||
| P304 | page(s) | 3-9 | |
| P577 | publication date | 2013-03-01 | |
| P1433 | published in | Eating and Weight Disorders | Q15749576 |
| P1476 | title | Therapeutic options for binge eating disorder | |
| P478 | volume | 18 |
Search more.